Miami, Florida – Global Stem Cells Group (GSCG) is delighted to announce the grand opening of ReGen Mediterra, a state-of-the-art facility located in the picturesque city of Antalya, Turkey. This new addition to the ReGen Network marks a significant advancement in the field of regenerative medicine and underscores GSCG’s dedication to providing innovative healthcare solutions on a global scale.
Expanding Medical Tourism in Antalya
Antalya, renowned for its breathtaking beaches and stunning landscapes, is one of Turkey’s most sought-after tourist destinations. The city’s allure as a premier hub for medical tourism is further amplified by the establishment of ReGen Mediterra. The facility is poised to attract patients not only from Turkey but from across Europe, seeking cutting-edge anti-aging treatments, advanced stem cell therapies, and non-invasive methods to address various health conditions.
Commitment to Excellence in Regenerative Medicine
“The expansion of the ReGen Clinic network solidifies our position as the largest regenerative medicine network globally. Antalya’s unique position as a top tourist destination makes it an ideal location for medical tourism, offering patients the opportunity to receive world-class treatments while enjoying the region’s natural beauty,” stated Dr. Salih Yildirim, Director of ReGen and President of the International Society for Stem Cell Application (ISSCA).
Stem cell therapy is emerging as an increasingly effective clinical solution for treating conditions that traditional medicine addresses primarily through palliative care and pain management. Patients worldwide are seeking natural regenerative alternatives that offer a reduced risk of potential side effects associated with conventional pharmaceuticals.
Advancing Accessibility and Training
The opening of ReGen Mediterra will facilitate the transition of stem cell therapy and regenerative medicine from elective procedures to accessible treatments for patients throughout Turkey. In addition to providing advanced treatments, the center will serve as a training hub for the International Society for Stem Cell Application (ISSCA), thereby enhancing the knowledge and expertise of healthcare professionals in the region.
Inauguration Ceremony and Conference Highlights
The inauguration ceremony was complemented by a conference, offering regional physicians an opportunity to gain insights into the latest technologies in regenerative medicine and cell therapy. This event underscores GSCG’s commitment to fostering education and collaboration within the medical community.
Future Prospects
As ReGen Mediterra begins its operations, it aims to set new benchmarks in the field of regenerative medicine. The facility will focus on delivering patient-centric care, leveraging the latest advancements in medical technology, and maintaining the highest standards of clinical practice. By doing so, GSCG hopes to make significant contributions to the well-being of patients and the advancement of medical tourism in Antalya.
About Global Stem Cells Group
Global Stem Cells Group is a leading provider of regenerative medicine solutions, dedicated to advancing healthcare through innovative therapies. With a global presence and a multidisciplinary team of experts, the organization strives to harness the potential of stem cells and regenerative medicine to improve patient outcomes across various medical fields. Through its extensive network of clinics, research facilities, and training centers, Global Stem Cells Group is committed to pushing the boundaries of regenerative medicine and making a positive impact on global healthcare.
Global Stem Cells Group is a publicly traded company operating under the symbol MSSV. https://finance.yahoo.com/quote/mssv/
To learn more about Global Stem Cells Group, Inc.’s companies visit our website www.stemcellsgroup.com or call +1 305 560 5331
About ReGen
ReGen is a highly acclaimed Turkish company with clinics in Turkey and several other locations around the world, renowned for its expertise in cutting-edge technologies related to regenerative care. Headquartered in Istanbul, ReGen has gained international recognition for its commitment to excellence and its groundbreaking advancements in regenerative medicine. By partnering with Global Stem Cells Group, ReGen aims to share its advanced techniques and expertise on a global scale, improving access to regenerative care and transforming lives worldwide.
Safe Harbor Statement: Statements in this news release may be “forward-looking statements”. Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions, or any other information relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates, and projections about our business based partly on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties, and assumptions that are difficult to predict. Therefore, actual outcomes and results may and are likely to differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release, and The Global Stem Cells Group undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release. This press release does not constitute a public offer of any securities for sale. Any securities offered privately will not be or have not been registered under the Act and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.
